mRNA SARS-CoV-2 vaccination before vs. during pregnancy and omicron infection among infants

JAMA Network Open

2023-11-10

(Press-News.org) About The Study: Maternal mRNA vaccination was associated with a lower risk of Omicron SARS-CoV-2 infection among infants up to six months of age only if the vaccine was given during the antenatal period in this study of 7,292 infants in Singapore. These findings suggest that mRNA vaccination during pregnancy may be needed for lower risk of SARS-CoV-2 infection among newborns.

Authors: Orlanda Goh, M.B., B.S., M.P.H., of Singapore General Hospital in Singapore, and Chee Fu Yung, M.B.Ch.B., of KK Women’s and Children’s Hospital in Singapore, are the corresponding authors.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2023.42475)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2023.42475?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111023

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

How mega-floods can be predicted

2023-11-10

What can we expect in the worst-case scenario? In regions with a high risk of flooding, this is an important question: what extreme events should the protective measures be designed for? Often this is answered simply by looking at history: The worst flood events of the past decades or centuries are regarded as a realistic upper limit for what can be expected in the future. However, this can be misleading, as so-called "mega-floods" have shown in recent years. Time and again, extreme flood events occur, extraordinary outliers that were not considered possible on the basis of local data. However, a major research project carried out under the leadership ...

The governance gap: Balancing innovation and ecological responsibility in a world at risk

2023-11-10

“The world isn’t doing terribly well in averting global ecological collapse,” says Dr Florian Rabitz, a researcher at Kaunas University of Technology (KTU), Lithuania, the author of a new monograph Transformative Novel Technologies and Global Environmental Governance recently published by Cambridge University Press. Greenhouse gas emissions, species extinction, ecosystem degradation, chemical pollution, and more are threatening the Earth’s future. Despite decades of international agreements and countless high-level ...

Impact of climate change on drylands to be examined with Royal Society award

2023-11-10

A leading researcher has been awarded a prestigious Royal Society Fellowship worth over £1.4 million to study how dryland landscapes respond to a changing climate. Dr Monika Markowska will join Northumbria University in January 2024 as part of her Royal Society University Research Fellowship. The Royal Society is the world’s oldest independent scientific academy, bringing together many of the world’s most distinguished scientists drawn from all areas of science, engineering, and medicine. Specialising in the variability of the Earth’s past climate, Dr Monika Markowska is an Isotope Geochemist, who is currently based at Max Planck ...

Yeast cells can produce drugs for treatment of psychotic disorders

2023-11-10

Production of biological substances for medicine using genetically engineered yeast cells shows new promising results in basic research from an international team of researchers. In 2022, the researchers attracted international attention by programming the longest-ever biosynthetic pathway - or 'assembly line' - into a microbial cell factory and designing it to produce biological substances for cancer drugs. In an article published in the scientific journal Nature Chemical Biology, Biosynthesis of natural and halogenated plant monoterpene indole alkaloids in yeast, the researchers now present results with the artificial production ...

New work sheds light on inner working of cells

2023-11-10

CÚRAM researchers at University of Galway, together with colleagues at the Centre for Molecular Nanometrology at University of Strathclyde have published work unveiling the inner workings of cells. Published recently in the German scientific journal Angewandte Chemie, the work provides a deeper understanding of the way components within cells are interconnected. This research has been on the agenda of scientists worldwide for many years, and has yielded plenty of useful information on how certain diseases behave. Through cellular visualisation using SRS microscopy, ...

Stable and efficient robotic artificial muscles built upon new material combinations

2023-11-10

Actuators, which convert electrical energy into motion or force, play a pivotal role in daily life, albeit often going unnoticed. Soft material-based actuators, in particular, have gained scientific attention in recent years due to their lightweight, quiet operation, and biodegradability. A straightforward approach to creating soft actuators involves employing multi-material structures, such as "pockets" made of flexible plastic films filled with oils and coated with conductive plastics. When subjected to electrical activation, the film displaces the fluid and contracts the pocket, similar to a biological muscle. This system ...

Initial patient dosed in Phase 2a clinical trial evaluating first-in-class human milk-based therapy in patients undergoing stem cell transplantation for blood cancers

2023-11-10

DUARTE, Calif., Nov. 10, 2023 – In a breakthrough for human milk science, researchers at City of Hope, Los Angeles, have dosed the first patient in a Phase 2a clinical trial evaluating a novel therapy for blood cancer patients undergoing allogeneic hematopoietic stem cell transplantation. The investigational treatment, PBCLN-010 in combination with PBCLN-014, combines human milk sugars with a strain of bacteria found in the gut of nursing infants. “Previous clinical trials of PBCLN-010 + PBCLN-014 have shown that it can safely and predictably control the gut microbiome ...

UVA launches futures initiative to chart next decade in higher ed

2023-11-10

With an eye toward a decade ahead that promises change, opportunity, and challenge, the University of Virginia on Friday launched its Futures Initiative to help plan for the next 10 years in higher education. Over the next year, a group of thought leaders from across the University, known as the Futures Initiative Group, will examine the current drivers of change in academia, such as artificial intelligence and large language models like ChatGPT, while also looking ahead to the eventual impact of sensor technology, virtual classrooms, the Internet of Things, and myriad other technological changes. The goal of the initiative—which was announced at Datapalooza 2023, an annual event ...

Regenstrief, IMIA, IAHSI and AMIA hosting mini-summit at AMIA 2023 Annual Symposium to address health effects of climate change

2023-11-10

INDIANAPOLIS -- Regenstrief Institute, the International Medical Informatics Association (IMIA), the International Academy of Health Sciences Informatics (IAHSI) and the American Medical Informatics Association (AMIA) are hosting a mini-summit at the AMIA 2023 Annual Symposium to address how informatics can help resolve health issues caused by climate change. The event will bring together national and international experts to form an informatics infrastructure that will highlight and bring exposure to climate change's effects on health. The event Mini-Summit 2023 -- Climate and health: How can informatics help? was planned because of the growing awareness around ...

Howard Meyers establishes Meyers Institute for Oncology Nursing with $25 million gift to MD Anderson

2023-11-10

HOUSTON ― Howard Meyers, of Dallas, Texas, a member of The University of Texas MD Anderson Cancer Center Board of Visitors (BOV), has committed $25 million to The University of Texas MD Anderson Cancer Center to establish the Meyers Institute for Oncology Nursing. The first of its kind, the Meyers Institute for Oncology Nursing will support and develop nurses throughout their careers by providing educational, professional and wellness-based resources tailored to cancer care nurses and nurse scientists. This ...

Menarini Group and Insilico Medicine enter a second exclusive global license agreement for an AI discovered preclinical asset targeting high unmet needs in oncology

mRNA SARS-CoV-2 vaccination before vs. during pregnancy and omicron infection among infants

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: